Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis

Detalles Bibliográficos
Autores principales: Garnero, Martina, Fabbri, Sabrina, Gemelli, Chiara, Benedetti, Luana, Mancardi, Giovanni Luigi, Schenone, Angelo, Grandis, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765263/
https://www.ncbi.nlm.nih.gov/pubmed/29141277
http://dx.doi.org/10.3988/jcn.2018.14.1.98
_version_ 1783292199920730112
author Garnero, Martina
Fabbri, Sabrina
Gemelli, Chiara
Benedetti, Luana
Mancardi, Giovanni Luigi
Schenone, Angelo
Grandis, Marina
author_facet Garnero, Martina
Fabbri, Sabrina
Gemelli, Chiara
Benedetti, Luana
Mancardi, Giovanni Luigi
Schenone, Angelo
Grandis, Marina
author_sort Garnero, Martina
collection PubMed
description
format Online
Article
Text
id pubmed-5765263
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korean Neurological Association
record_format MEDLINE/PubMed
spelling pubmed-57652632018-01-12 Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis Garnero, Martina Fabbri, Sabrina Gemelli, Chiara Benedetti, Luana Mancardi, Giovanni Luigi Schenone, Angelo Grandis, Marina J Clin Neurol Letter to the Editor Korean Neurological Association 2018-01 2017-09-27 /pmc/articles/PMC5765263/ /pubmed/29141277 http://dx.doi.org/10.3988/jcn.2018.14.1.98 Text en Copyright © 2018 Korean Neurological Association http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Garnero, Martina
Fabbri, Sabrina
Gemelli, Chiara
Benedetti, Luana
Mancardi, Giovanni Luigi
Schenone, Angelo
Grandis, Marina
Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
title Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
title_full Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
title_fullStr Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
title_full_unstemmed Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
title_short Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
title_sort subcutaneous immunoglobulins are a valuable treatment option in myasthenia gravis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765263/
https://www.ncbi.nlm.nih.gov/pubmed/29141277
http://dx.doi.org/10.3988/jcn.2018.14.1.98
work_keys_str_mv AT garneromartina subcutaneousimmunoglobulinsareavaluabletreatmentoptioninmyastheniagravis
AT fabbrisabrina subcutaneousimmunoglobulinsareavaluabletreatmentoptioninmyastheniagravis
AT gemellichiara subcutaneousimmunoglobulinsareavaluabletreatmentoptioninmyastheniagravis
AT benedettiluana subcutaneousimmunoglobulinsareavaluabletreatmentoptioninmyastheniagravis
AT mancardigiovanniluigi subcutaneousimmunoglobulinsareavaluabletreatmentoptioninmyastheniagravis
AT schenoneangelo subcutaneousimmunoglobulinsareavaluabletreatmentoptioninmyastheniagravis
AT grandismarina subcutaneousimmunoglobulinsareavaluabletreatmentoptioninmyastheniagravis

Ejemplares similares